End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
46.21 CNY | +0.65% | +1.27% | +2.17% |
Mar. 27 | Hengrui Pharma Gets Nod for Injectable Cancer Drug Trial | MT |
Mar. 19 | Hengrui Pharma Gets Green Light to Trial Four Cancer Drugs | MT |
Business Summary
- anti-tumor drugs (No. 1 Chinese);
- Anesthetic drugs;
- contrast agents: used in medical imaging;
- anti-inflammatory drugs;
- drugs for the treatment of cardiovascular diseases.
Number of employees: 20,636
Sales per Business
CNY in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Anti-tumor
53.2
%
| 13,072 | 50.5 % | 11,313 | 53.2 % | -13.45% |
Others
18.0
%
| 4,523 | 17.5 % | 3,836 | 18.0 % | -15.19% |
Anesthesia
15.7
%
| 4,916 | 19.0 % | 3,336 | 15.7 % | -32.15% |
Contrast Agent
12.8
%
| 3,270 | 12.6 % | 2,729 | 12.8 % | -16.54% |
Other Business
0.3
%
| 125 | 0.5 % | 62 | 0.3 % | -50.29% |
Sales per region
CNY in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
China
96.3
%
| 25,164 | 97.6 % | 20,434 | 96.3 % | -18.80% |
Abroad
3.7
%
| 617 | 2.4 % | 779 | 3.7 % | +26.37% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Hong Bin Dai
CEO | Chief Executive Officer | 48 | 00-06-30 |
Jian Jun Liu
DFI | Director of Finance/CFO | 47 | 21-11-18 |
Yu Xu
CMP | Compliance Officer | 32 | 21-05-31 |
Ning Jun Jiang
BRD | Director/Board Member | 63 | 23-02-01 |
Guo Qiang Xiong
BRD | Director/Board Member | 49 | 04-12-31 |
Lian Shan Zhang
BRD | Director/Board Member | 63 | 10-08-05 |
Jie Ping Sun
BRD | Director/Board Member | 54 | 97-12-31 |
Fei Tian
IRC | Investor Relations Contact | - | - |
Xiao Han Liu
SEC | Corporate Secretary | 39 | 11-07-31 |
Su Mei Jiang
PRN | Corporate Officer/Principal | 61 | 99-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jie Ping Sun
BRD | Director/Board Member | 54 | 97-12-31 |
Hong Bin Dai
CEO | Chief Executive Officer | 48 | 00-06-30 |
Piao Yang Sun
CHM | Chairman | 66 | 03-02-28 |
Su Mei Jiang
PRN | Corporate Officer/Principal | 61 | 99-12-31 |
Kai Hong Yuan
CHM | Chairman | - | 86-12-31 |
Lian Shan Zhang
BRD | Director/Board Member | 63 | 10-08-05 |
Guo Qiang Xiong
BRD | Director/Board Member | 49 | 04-12-31 |
Ning Jun Jiang
BRD | Director/Board Member | 63 | 23-02-01 |
Cong Zhao Guo
BRD | Director/Board Member | 52 | 20-01-15 |
Yu Xu
CMP | Compliance Officer | 32 | 21-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 6,379,002,274 | 3,258,210,645 ( 51.08 %) | 20,442,448 ( 0.3205 %) | 51.08 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
22,254,027 | 0.35% | 131,916,976 $ |
Company contact information
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
7 Kunlunshan Road Economic & Technological Devt Zone
222000, Lianyungang
+
http://www.hengrui.comSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.50% | 40.39B | |
+33.50% | 701B | |
+26.24% | 571B | |
+0.78% | 381B | |
+20.85% | 334B | |
+16.38% | 319B | |
+2.78% | 210B | |
+0.96% | 210B | |
-6.69% | 201B | |
-3.51% | 157B |
- Stock
- Equities
- Stock Jiangsu Hengrui Medicine Co., Ltd. - Shanghai S.E.
- Company Jiangsu Hengrui Medicine Co., Ltd.